Literature DB >> 16597074

Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study.

Raymond G Slavin1, Tmirah Haselkorn, June H Lee, Beiyao Zheng, Yamo Deniz, Sally E Wenzel.   

Abstract

BACKGROUND: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) was a 3-year, multicenter, observational study of 4,756 patients 6 years or older with severe or difficult-to-treat asthma by physician evaluation. More than 280 pulmonologist and allergist sites across the United States participated.
OBJECTIVE: To compare health care utilization (HCU), medication use, asthma control, and quality of life (QoL) in older (> or =65 years; n = 566) and younger (18-64 years; n = 2,912) adult patients in TENOR.
METHODS: Patients had to be under a physician's care for at least 1 year and have high medication use or HCU in the past year. Heavy smokers (> or =30 pack-years) and patients with cystic fibrosis were excluded.
RESULTS: Although older patients in TENOR had worse lung function as measured by decreased percent predicted forced expiratory volume in 1 second (FEV1) (P < .001), they had significantly lower HCU compared with younger patients. They also had higher use of inhaled corticosteroids and better QoL than younger patients. Older patients reported fewer problems controlling their asthma (P < .001) but reported worse communication with their physicians (P = .02).
CONCLUSIONS: Older patients in TENOR appeared to do better than younger patients, despite having worse lung function. Older patients in TENOR may have received more aggressive care than older asthmatic patients in other studies, based on a higher use of inhaled and oral corticosteroids. Whether differences in treatment or disease influenced other physiologic or inflammatory outcomes that contribute to the disconnect between HCU and FEV1 awaits further study.

Entities:  

Mesh:

Year:  2006        PMID: 16597074     DOI: 10.1016/S1081-1206(10)60907-6

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  23 in total

Review 1.  The immune system in the aging human.

Authors:  Paulina Dominika Rymkiewicz; Yi Xiong Heng; Anusha Vasudev; Anis Larbi
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 2.  Targeted Therapy for Older Patients with Uncontrolled Severe Asthma: Current and Future Prospects.

Authors:  E W de Roos; J C C M In 't Veen; G-J Braunstahl; L Lahousse; G G O Brusselle
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

3.  Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Thomas M Gill
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

Review 4.  Role of allergen sensitization in older adults.

Authors:  Ravi K Viswanathan; Sameer K Mathur
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

5.  Changes in immune function in asthma in the elderly.

Authors:  Sameer K Mathur; Sharmilee M Nyenhuis
Journal:  Aging health       Date:  2009-09

Review 6.  Allergy and asthma in the elderly.

Authors:  Sameer K Mathur
Journal:  Semin Respir Crit Care Med       Date:  2010-10-12       Impact factor: 3.119

7.  Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.

Authors:  Bradley E Chipps; Robert S Zeiger; Larry Borish; Sally E Wenzel; Ashley Yegin; Mary Lou Hayden; Dave P Miller; Eugene R Bleecker; F Estelle R Simons; Stanley J Szefler; Scott T Weiss; Tmirah Haselkorn
Journal:  J Allergy Clin Immunol       Date:  2012-06-12       Impact factor: 10.793

8.  Recovery and survival from aging-associated diseases.

Authors:  Igor Akushevich; Julia Kravchenko; Svetlana Ukraintseva; Konstantin Arbeev; Anatoliy I Yashin
Journal:  Exp Gerontol       Date:  2013-05-23       Impact factor: 4.032

Review 9.  The irreversible component of persistent asthma.

Authors:  Rodolfo M Pascual; Stephen P Peters
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

10.  Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial.

Authors:  Mario Castro; Adalberto S Rubin; Michel Laviolette; Jussara Fiterman; Marina De Andrade Lima; Pallav L Shah; Elie Fiss; Ronald Olivenstein; Neil C Thomson; Robert M Niven; Ian D Pavord; Michael Simoff; David R Duhamel; Charlene McEvoy; Richard Barbers; Nicolaas H T Ten Hacken; Michael E Wechsler; Mark Holmes; Martin J Phillips; Serpil Erzurum; William Lunn; Elliot Israel; Nizar Jarjour; Monica Kraft; Narinder S Shargill; John Quiring; Scott M Berry; Gerard Cox
Journal:  Am J Respir Crit Care Med       Date:  2009-10-08       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.